Pfizer News

• Pfizer CEO says 2023 will be ‘transition year’ as it sees drop in COVID sales

  Pfizer Inc on Tuesday forecast a bigger-than-expected drop in sales of its COVID-19 vaccine and treatment for 2023, intensifying investor concerns over demand for the products.

  Money

  Jan 31, 2023
  
• Updated Pfizer Omicron booster protects against subvariants, company says

  The companies said data from a trial in adult patients showed that the booster dose led to a substantial increase in neutralizing antibody levels against the BA.4/BA.5 variants.

  World

  Oct 13, 2022
  
• Advertisement
• Moderna suing Pfizer over patent for ‘foundational’ COVID-19 mRNA vaccine

  Moderna announced the lawsuits and alleged that the Pfizer/BioNTech vaccine 'infringes patents Moderna filed between 2010 and 2016 covering Moderna's foundational mRNA technology.'

  Canada

  Aug 26, 2022
• Advertisement
• Pfizer booster for kids 5 to 11 helps protect against Omicron variant, company says

  Pfizer and BioNTech said the data reinforces potential function of a third dose of the vaccine in maintaining high levels of protection against the virus in this age group.

  World

  Apr 14, 2022
• Pfizer’s COVID pill is in short supply. Should unvaccinated be prioritized?

  "Paxlovid is just yet another piece of the puzzle that helps us manage this illness in people who may be at more risk," said Dr. Gerald Evans of the new COVID-19 treatment.

  Health

  Jan 18, 2022
• Pfizer to buy Arena Pharmaceuticals as it expands treatment pipeline

  This is the latest deal Pfizer has struck this year to expand treatment pipeline.

  Health

  Dec 13, 2021
• New Pfizer COVID-19 pill reduces hospital, death risk by 90%, company says

  Pfizer's pill to treat COVID-19 reduces the risk of hospitalization and death by nearly 90 per cent, the company said Friday when it released preliminary results.

  Health

  Nov 5, 2021